ANV-419
N/A
Report date: 2024/03/28 17:42:04
Base Information
Drug NameANV-419
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnaveon AG
China Registration ClassN/A
Develop Information
Active CompaniesVall D'Hebron Institute Of OncologyAnaveon AG
Inactive CompaniesN/A
Active Indications +[5]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A